New aromatic lactone derivatives with inhibitory activities on nitric oxide production from Homalium stenophyllum

Publication date: June 2018 Source:Phytochemistry Letters, Volume 25 Author(s): Shou-Yuan Wu, Yan-Hui Fu, Qi Zhou, Meng Bai, Guang-Ying Chen, Si-Yu Zhao, Xiao-Ping Song, Chang-Ri Han Two new aromatic lactone derivatives, homastenones A (1) and B (2), together with six known compounds (3–8), were isolated from the stems of Homalium stenophyllum. Their structures were established on the basis of extensive spectroscopic analyses. Among them, homastenones A (1) and B (2) are two novel aromatic lactone derivatives containing 12 carbon atoms on the carbon skeleton, and the known compounds (3–8) were isolated from this plant for the first time. All new compounds were evaluated for their inhibitory activities on nitric oxide (NO) production induced by lipopolysaccharide in mouse macrophage RAW 264.7 cells in vitro. Compounds 1 and 2 exhibited inhibitory activities with IC50 values of 12.25 ± 0.45 and 25.36 ± 1.65 μM, respectively. Graphical abstract
Source: Phytochemistry Letters - Category: Chemistry Source Type: research

Related Links:

Publication date: Available online 21 November 2019Source: Journal of Cancer PolicyAuthor(s): Brandon Maser, Lisa M. Force, Paola Friedrich, Federico Antillon, Ramandeep S. Arora, Cristian A. Herrera, Carlos Rodriguez-Galindo, Rifat Atun, Avram DenburgAbstractTo help understand how health systems and sociopolitical contexts intersect with and impact the performance of childhood cancer care in low- and middle-income countries (LMICs), we have developed a systems-level framework for analyzing the performance of LMIC childhood cancer programs within their health system contexts: The Paediatric Oncology System Integration Tool...
Source: Journal of Cancer Policy - Category: Cancer & Oncology Source Type: research
Future Oncology, Ahead of Print.
Source: Future Oncology - Category: Cancer & Oncology Authors: Source Type: research
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.
Source: Cancer Biotherapy and Radiopharmaceuticals - Category: Cancer & Oncology Authors: Source Type: research
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.
Source: Cancer Biotherapy and Radiopharmaceuticals - Category: Cancer & Oncology Authors: Source Type: research
Date: Thursday, 12 12, 2019; Speaker: Julie Blendy , Ph.D. Professor of Pharmacology, Perelman School of Medicine, University of Pennsylvania; Building: Building 40; 1201/1203
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Thursday, 12 19, 2019; Speaker: Cristine Delnevo, Ph.D., M.P.H., F.A.A.H.B., Director, Center for Tobacco Studies, Society and Policy Rutgers School of Public Health; Nir Eyal, D.Phil, Director, Center for Population-Level Bioethics (CPLB), Society and Policy Rutgers School of Public Health; https://epi.grants.cancer.gov/events/enrich-forum/
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Monday, 01 27, 2020; Speaker: Lisa Ingraham, Ph.D., University of California, San Francisco; Porter Neuroscience Bldg, 35a; G620-640; Videocast Event
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Friday, 11 22, 2019; Speaker: various; Building 38; Conference room B, second floor
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Friday, 11 22, 2019; Speaker: Nicola Santoro, MD, PhD, Assistant Professor of Pediatrics (Endocrinology), Yale School of Medicine; Building 10 CRC; FAES 1&2
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Monday, 11 25, 2019; Speaker: Eugene M. Oltz , Chair of the Department of Microbial Infection and Immunity , College of Medicine – The Ohio State University; 37; 6041
Source: NIH Calendar of Events - Category: American Health Source Type: events
More News: Men